查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1483137

醫學美容市場評估：依產品類型、依應用類型、依最終用戶、依地區、機會、預測，2017-2031 年

Medical Aesthetics Market Assessment, By Product Type, By Application Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 221 Pages | 商品交期: 3-5個工作天內

價格

全球醫學美容市場規模預計將從2023年的208.4億美元成長到2031年的495.8億美元，在2024-2031年的預測期內複合年增長率為11.44%。醫學美容，也稱為整容手術，是由美容師使用微創美容設備進行，並透過手術改善患者的體驗。這些設備用途極為廣泛，可執行各種手術來解決各種問題，包括身體輪廓、去除紋身、除毛、皮膚老化和埋葬技術。這些設備可讓您根據個人喜好制定個人化治療方案，確保最大程度的滿意度。

醫療美容市場預計在未來幾年將大幅擴張。由於老年人口不斷增長、技術進步、人們對手術潛在結果的認識提高以及收入和生活水平的提高等因素，該市場有可能進一步擴大。業界的公司和醫療保健從業者共同努力為患者提供最佳的工具和美容解決方案。公共和商業組織都在籌集資金並進行大量投資，以提供優質的解決方案。這些大公司利用聯盟、投資和併購等策略性措施來提高其在市場上的影響力。Sciton Inc. 宣佈將於 2023 年擴展其 mJOULE 系統，增加兩種血管治療藥物，稱為 ClearV 和 ClearSilk。透過此次擴張，該公司加強了其基於能量的美容設備的產品組合，並將自己定位為為醫療保健專業人員提供先進解決方案的值得信賴的領導者。

該報告審視了全球醫學美容市場，並提供了市場概況，包括依產品類型、應用類型、最終用戶、地區和進入市場的公司概況劃分的趨勢。

目錄

第一章研究方法論

第二章 專案範圍與定義

第三章執行摘要

第四章 2017-2031年全球醫美市場展望

  • 市場規模及預測
  • 依產品類型
  • 依使用類型
  • 依最終用戶
  • 依地區
  • 依公司劃分的市佔率 (%)，2023 年

第五章 2017-2031 年全球醫療美容市場前景（依地區）

  • 北美
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東/非洲

第 6 章 市場測繪，2023 年

第七章 宏觀環境與產業結構

  • 供需分析
  • 進出口分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第八章市場動態

第九章 監理架構與創新

第十章 主要與企業狀況

第11章價格分析

第十二章案例研究

第十三章 主要進入者展望

  • Allergan, Inc.
  • Alma Lasers Ltd.
  • Cynosure Technologies (P) Ltd.
  • Bausch Health Companies Inc.
  • Johnson & Johnson Services, Inc.
  • Boston Scientific Corporation
  • Galderma S.A.
  • Cutera, Inc.
  • Candela Corp.
  • Venus Concept Inc.

第十四章 戰略建議

第十五章 查詢及免責聲明

Product Code: MX11374

Global medical aesthetics market is projected to witness a CAGR of 11.44% during the forecast period 2024-2031, growing from USD 20.84 billion in 2023 to USD 49.58 billion in 2031. Medical aesthetics, also known as cosmetic procedures, are done by aestheticians using cosmetic devices that are minimally invasive and enhance the patient's experience through the procedures. These devices can be very versatile in performing different procedures that address a wide variety of concerns, such as body contouring, tattoo removal, hair removal, skin aging, implantations, and much more. These devices can personalize treatment options according to individual preferences, ensuring maximum satisfaction.

The market for medical aesthetics is anticipated to expand significantly in the upcoming years. This market has the potential to expand further due to factors such as the increasing geriatric population, technological advancements, increased awareness about the possible surgical outcomes that can be achieved through surgery, and increasing income and living standards. Companies in the industry and healthcare practitioners are collaborating to provide the best tools and cosmetic solutions for patients. Both public and commercial organisations are raising money and investing a significant amount to provide quality solutions. These massive corporations use strategic maneuvers like collaborations, investments and mergers and acquisitions to increase their presence in the market. Sciton Inc. announced the expansion of its mJOULE system in 2023, which includes two vascular treatments called as ClearV and ClearSilk. This expansion has helped the company strengthen its product portfolio in energy-based aesthetic devices and mark its position as a trusted leader in delivering advanced solutions to healthcare professionals.

Technological Advancements in the Medical Aesthetics Market

Technological developments are significantly influencing the medical aesthetics sector in developed countries. New instruments and techniques are being launched that prioritize patient pleasure, safety, and effectiveness. In dermatology, minimally invasive procedures like chemical peels, laser therapy, and microdermabrasion have become standard practices. The scope of treatment and possibilities is driving the demand for aesthetic services these procedures provide patients to address a variety of skin issues with little discomfort and downtime. With the use of advanced imaging technology, such as 3D models and high-resolution cameras, dermatologists can precisely diagnose patients' skin diseases and adjust treatment regimens accordingly. Before having operations, patients can envision possible outcomes, which promotes informed decision-making and increases overall satisfaction. The delivery of these services has been revolutionized by telemedicine platforms, enabling patients to visit dermatologists remotely and receive professional advice from the comfort of their homes.

This telemedicine has proven helpful for those who may not have easy access to specialised treatment and live in rural or underdeveloped locations. Patients may track the effectiveness of their treatments, keep an eye on the condition of their skin, and get customized skincare advice with the use of wearable technology and smartphone apps. Increased patient participation and adherence to treatment plans are encouraged by this, which eventually improves results. In 2022, GC Aesthetics, Inc. (GCA), a privately held medical technology business offering healthcare aesthetic solutions, announced the release of FixNip NRI, an innovative implant for the reconstruction of the nipple areola complex (NAC). The company has devised a solution to reconstruct the nipple areola complex for thousands of women worldwide.

Marketing and Advertising Strategies Contribute to Rising Awareness

Reputed brands provide confidence and trust to their consumers about their surgical procedures and devices through advertising. Advertising provides a forum for informing prospective patients about different cosmetic procedures, the benefits of different devices and procedures, and the expected results, guaranteeing that they have access to relevant and reliable information. Before-and-after photos, films, and visual demonstrations are frequently used in creative advertising to highlight the effectiveness of medical aesthetic equipment and help prospective patients visualize possible outcomes.

Marketers use data and consumer insights to target specific demographics and audiences to ensure that their marketing efforts reach those most likely to be interested in aesthetic procedures. Patient evaluations and testimonials, which provide real-life experiences and success stories, are widely used in advertising campaigns to build trust and credibility. Partnerships and collaborations with celebrities and social media influencers who use certain technologies or have undergone cosmetic procedures can greatly impact their fan base and quickly raise awareness and interest. To facilitate better decision-making, some clinics and device makers use interactive tools like augmented reality (AR) applications that let prospective patients see possible treatment results. For example, a special Mother's Day discount was introduced in March 2024 by an aesthetic medicine clinic named Shine Medical Cosmetic Clinic, located in Kenilworth, United Kingdom. Along with many procedures discounted by up to USD 54.28 (£50), Shine Medical Cosmetic Clinic also provides a complimentary LED treatment with each radiant glow peel. With a variety of reasonably priced treatments, Shine Medical Cosmetic Clinic, headed by Dr. Shyna Raj, hopes to assist clients in achieving their cosmetic aspirations.

Botulinum Toxin Segment Leads the Global Medical Aesthetics Market

The bacteria clostridium botulinum produces the neurotoxic protein known as botulinum toxin. Injections of botulinum toxin typically obstructs nerve signals to the targeted muscle. The muscle reduces or lessens undesirable face wrinkles because it cannot contract without a signal. Therefore, both cosmetic and non-cosmetic treatments require very diluted quantities of botulinum toxin, including the treatment of dystonia, persistent migraines, frown lines between the eyebrows, and other such conditions. The market category is expanding due to factors such as the growing popularity of botulinum toxin operations among young adults, the increasing demand for less invasive cosmetic procedures, an increase in the number of people who are mindful of their appearance, and the introduction of new products. According to the American Society of Plastic Surgeons poll, one of the most popular minimally invasive cosmetic procedures among patients is botulinum toxin Type A. Also, it was noted that patients between the ages of 31 and 45 most frequently seek out cosmetic botulinum toxin type A operations. The key competitors in the market are also making significant investments in technical advancements and increasing their import and export of products containing botulinum toxin. In September 2022, Revance Therapeutics Inc.'s USFDA authorised DAXXIFY (DaxibotulinumtoxinA-lanm) received an approval for injection to treat adults with moderate to temporarily severe frown lines (glabellar lines).

North America Dominates the Global Medical Aesthetics Market

The market for medical aesthetic devices in North America is anticipated to develop significantly because of the region's advancements in technology, growing awareness of aesthetic and minimally invasive procedures, and the rising volume of various aesthetic procedures performed in the United States and Canada. The region's high rate of aesthetic operations generates demand for aesthetic devices, which in turn propels the market's expansion. High concentration of major players in North America are promoting product launches, which is also an important factor contributing to the regional market's expansion. Mentor Worldwide LLC, a division of the Johnson & Johnson Medical Devices Companies, declared in January 2022 that the MENTOR MemoryGel BOOST breast implant for breast augmentation and reconstruction has received FDA approval. This product has supported the company to expand its portfolio in the United States market. Allergan, a division of AbbVie Inc., announced in February 2022 that JUVEDERM VOLBELLA XC received FDA approval for the treatment of infraorbital hollows in people over the age of 21.

Future Market Scenario (2024-2031F)

One of the main factors contributing to the anticipated growth of the medical aesthetics market is the increasing awareness and desire to achieve the best possible physical features in the general population. Given that technology is serving the best quality results expected by people, satisfaction level with these kinds of treatments is very high. Players in this market are expanding at an unparalleled rate, introducing advanced and efficient aesthetic surgery technologies. For instance, Cynosure released the PicoSure Pro device in June 2022, marking the most recent iteration of the PicoSure platform. PicoSure Pro is one of the first 755 nm picosecond lasers to receive FDA clearance. Similarly, Gladerma launched its FACE by Gladerma in 2023, which is an augmented reality tool. It enables the professionals and patients to preview the possible results of any injectable procedure to achieve the best results. The government is enacting new laws and generating money to enhance the quality of healthcare provided globally.

Key Players Landscape and Outlook

Several companies such as Allergan, Inc., Alma Lasers Ltd., Cynosure Technologies (P) Ltd., Bausch Health Companies Inc., Johnson & Johnson Services, Inc., Boston Scientific Corporation, Galderma S.A., Cutera, Inc., Candela Corp., Venus Concept Inc., etc., are expanding their businesses by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launches of newly developed cosmetology techniques and devices, to help researchers and to bring up their presence in the market.

In August 2022, the Allergan Aesthetics business unit of Allergan Healthcare India Private Limited, a Bangalore-based company, announced the launch of JUVEDERM VOLUX in India. Prior to releasing this medication on the Indian market, Allergan Aesthetics secured the required approvals from the Central Drugs Standards Control Organisation (CDSCO), according to a news statement from the firm. JUVEDERM VOLUX is an injectable implant based on hyaluronic acid that restores and enhances facial volume. It contains 3 mg of lidocaine hydrochloride and 25 mg of hyaluronic acid. With specific claims to strengthen and improve the jawline and chin, giving the appearance of a more defined and improved chin, VOLUX is a hyaluronic acid dermal filler designed for use in these areas.

Menarini India, a branch of the Italian Menarini Group, announced its entry into the aesthetics market in September 2023. The company launched 'Definisse Core Filler' in the Indian market, demonstrating a strong dedication to continuous innovation and meeting the specific needs of the country's customer base. During 'Definisse Core Filler' launch 75 aesthetic dermatologists, cosmetologists, and cosmetic surgeons from all over India received practical training to provide them the know-how to use this filler.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Medical Aesthetics Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
  • 4.2.By Product Type
    • 4.2.1.Energy-based Aesthetic Device
      • 4.2.1.1.Laser-based Aesthetic Device
      • 4.2.1.2.Radiofrequency (RF)-based Aesthetic Device
      • 4.2.1.3.Light-based Aesthetic Device
      • 4.2.1.4.Ultrasound Aesthetic Device
    • 4.2.2.Non-energy-based Aesthetic Device
      • 4.2.2.1.Botulinum Toxin
      • 4.2.2.2.Dermal Fillers and Aesthetic Threads
      • 4.2.2.3.Microdermabrasion
      • 4.2.2.4.Implants
        • 4.2.2.4.1.Facial Implants
        • 4.2.2.4.2.Breast Implants
        • 4.2.2.4.3.Other Implants
      • 4.2.2.5.Other Aesthetic Devices
  • 4.3.By Application Type
    • 4.3.1.Skin Resurfacing and Tightening
    • 4.3.2.Body Contouring and Cellulite Reduction
    • 4.3.3.Hair Removal
    • 4.3.4.Breast Augmentation
    • 4.3.5.Other Applications
  • 4.4.By End-user
    • 4.4.1.Hospitals
    • 4.4.2.Beauty Aesthetics Clinics
  • 4.5.By Region
    • 4.5.1.North America
    • 4.5.2.Europe
    • 4.5.3.Asia-Pacific
    • 4.5.4.South End-user America
    • 4.5.5.Middle East and Africa
  • 4.6.By Company Market Share (%), 2023

5.Global Medical Aesthetics Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
    • 5.1.2.By Product Type
      • 5.1.2.1.Energy-based Aesthetic Device
        • 5.1.2.1.1.Laser-based Aesthetic Device
        • 5.1.2.1.2.Radiofrequency (RF)-based Aesthetic Device
        • 5.1.2.1.3.Light-based Aesthetic Device
        • 5.1.2.1.4.Ultrasound Aesthetic Device
      • 5.1.2.2.Non-energy-based Aesthetic Device
        • 5.1.2.2.1.Botulinum Toxin
        • 5.1.2.2.2.Dermal Fillers and Aesthetic Threads
        • 5.1.2.2.3.Microdermabrasion
        • 5.1.2.2.4.Implants
          • 5.1.2.2.4.1.Facial Implants
          • 5.1.2.2.4.2.Breast Implants
          • 5.1.2.2.4.3.Other Implants
        • 5.1.2.2.5.Other Aesthetic Devices
    • 5.1.3.By Application Type
      • 5.1.3.1.Skin Resurfacing and Tightening
      • 5.1.3.2.Body Contouring and Cellulite Reduction
      • 5.1.3.3.Hair Removal
      • 5.1.3.4.Breast Augmentation
      • 5.1.3.5.Other Applications
    • 5.1.4.By End-user
      • 5.1.4.1.Hospitals
      • 5.1.4.2.Beauty Aesthetics Clinics
    • 5.1.5.United States*
      • 5.1.5.1.Market Size & Forecast
        • 5.1.5.1.1.By Value
      • 5.1.5.2.By Product Type
        • 5.1.5.2.1.Energy-based Aesthetic Device
          • 5.1.5.2.1.1.Laser-based Aesthetic Device
          • 5.1.5.2.1.2.Radiofrequency (RF)-based Aesthetic Device
          • 5.1.5.2.1.3.Light-based Aesthetic Device
          • 5.1.5.2.1.4.Ultrasound Aesthetic Device
        • 5.1.5.2.2.Non-energy-based Aesthetic Device
          • 5.1.5.2.2.1.Botulinum Toxin
          • 5.1.5.2.2.2.Dermal Fillers and Aesthetic Threads
          • 5.1.5.2.2.3.Microdermabrasion
          • 5.1.5.2.2.4.Implants
          • 5.1.5.2.2.4.1.Facial Implants
          • 5.1.5.2.2.4.2.Breast Implants
          • 5.1.5.2.2.4.3.Other Implants
          • 5.1.5.2.2.5.Other Aesthetic Devices
      • 5.1.5.3.By Application Type
        • 5.1.5.3.1.Skin Resurfacing and Tightening
        • 5.1.5.3.2.Body Contouring and Cellulite Reduction
        • 5.1.5.3.3.Hair Removal
        • 5.1.5.3.4.Breast Augmentation
        • 5.1.5.3.5.Other Applications
      • 5.1.5.4.By End-user
        • 5.1.5.4.1.Hospitals
        • 5.1.5.4.2.Beauty Aesthetics Clinics
    • 5.1.6.Canada
    • 5.1.7.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East and Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Product Type
  • 6.2.By Application Type
  • 6.3.By End-user
  • 6.4.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat From New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Patent Landscape
  • 9.2.Regulatory Approval
  • 9.3.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.Allergan, Inc.
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products and Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus and Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Alma Lasers Ltd.
  • 13.3.Cynosure Technologies (P) Ltd.
  • 13.4.Bausch Health Companies Inc.
  • 13.5.Johnson & Johnson Services, Inc.
  • 13.6.Boston Scientific Corporation
  • 13.7.Galderma S.A.
  • 13.8.Cutera, Inc.
  • 13.9.Candela Corp.
  • 13.10.Venus Concept Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 3.Global Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 4.Global Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 5.Global Medical Aesthetics Market Share (%), By Region, 2017-2031F
  • Figure 6.North America Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 7.North America Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 8.North America Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 9.North America Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 10.North America Medical Aesthetics Market Share (%), By Country, 2017-2031F
  • Figure 11.United States Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 12.United States Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 13.United States Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 14.United States Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 15.Canada Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 16.Canada Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 17.Canada Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 18.Canada Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 19.Mexico Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 20.Mexico Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 21.Mexico Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 22.Mexico Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 23.Europe Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 24.Europe Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 25.Europe Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 26.Europe Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 27.Europe Medical Aesthetics Market Share (%), By Country, 2017-2031F
  • Figure 28.Germany Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 29.Germany Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 30.Germany Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 31.Germany Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 32.France Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 33.France Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 34.France Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 35.France Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 36.Italy Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 37.Italy Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 38.Italy Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 39.Italy Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 40.United Kingdom Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 41.United Kingdom Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 42.United Kingdom Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 43.United Kingdom Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 44.Russia Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 45.Russia Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 46.Russia Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 47.Russia Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 48.Netherlands Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 49.Netherlands Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 50.Netherlands Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 51.Netherlands Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 52.Spain Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 53.Spain Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 54.Spain Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 55.Spain Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 56.Turkey Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 57.Turkey Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 58.Turkey Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 59.Turkey Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 60.Poland Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 61.Poland Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 62.Poland Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 63.Poland Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 64.South America Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 65.South America Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 66.South America Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 67.South America Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 68.South America Medical Aesthetics Market Share (%), By Country, 2017-2031F
  • Figure 69.Brazil Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 70.Brazil Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 71.Brazil Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 72.Brazil Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 73.Argentina Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 74.Argentina Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 75.Argentina Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 76.Argentina Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 77.Asia-Pacific Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 78.Asia-Pacific Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 79.Asia-Pacific Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 80.Asia-Pacific Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 81.Asia-Pacific Medical Aesthetics Market Share (%), By Country, 2017-2031F
  • Figure 82.India Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 83.India Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 84.India Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 85.India Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 86.China Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 87.China Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 88.China Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 89.China Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 90.Japan Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 91.Japan Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 92.Japan Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 93.Japan Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 94.Australia Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 95.Australia Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 96.Australia Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 97.Australia Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 98.Vietnam Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 99.Vietnam Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 100.Vietnam Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 101.Vietnam Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 102.South Korea Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 103.South Korea Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 104.South Korea Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 105.South Korea Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 106.Indonesia Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 107.Indonesia Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 108.Indonesia Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 109.Indonesia Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 110.Philippines Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 111.Philippines Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 112.Philippines Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 113.Philippines Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 114.Middle East & Africa Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 115.Middle East & Africa Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 116.Middle East & Africa Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 117.Middle East & Africa Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 118.Middle East & Africa Medical Aesthetics Market Share (%), By Country, 2017-2031F
  • Figure 119.Saudi Arabia Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 120.Saudi Arabia Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 121.Saudi Arabia Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 122.Saudi Arabia Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 123.UAE Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 124.UAE Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 125.UAE Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 126.UAE Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 127.South Africa Medical Aesthetics Market, By Value, In USD Billion, 2017-2031F
  • Figure 128.South Africa Medical Aesthetics Market Share (%), By Product Type, 2017-2031F
  • Figure 129.South Africa Medical Aesthetics Market Share (%), By Application Type, 2017-2031F
  • Figure 130.South Africa Medical Aesthetics Market Share (%), By End-user, 2017-2031F
  • Figure 131.By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 132.By Application Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 133.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 134.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023